Gary A. Lyons - 01 Sep 2023 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Reporting relationship: Director
Issuer ticker: NBIX
Reported as of: 01 Sep 2023
Net transaction value: -$550,316
SEC form: 4
Accepted by SEC: 06 Sep 2023, 16:25:23 UTC
Prior SEC filing: 12 Jul 2023
Next SEC filing: 14 Sep 2023
Source filing: View source filing
Reporting owner signature: /s/ Darin Lippoldt, Attorney-in-Fact

Key filing fact

Gary A. Lyons filed Form 4 for NEUROCRINE BIOSCIENCES INC (NBIX) on 06 Sep 2023.

Key facts

This page summarizes Gary A. Lyons's Form 4 filing for NEUROCRINE BIOSCIENCES INC (NBIX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Sep 2023, 16:25.

Change

Previous filing in this sequence was filed on 12 Jul 2023.
Current net transaction value: -$550,316.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NBIX transaction

Common Stock

Options Exercise

Transaction value: $64,900
Shares: +5,000
Change %: +2.5%
Price: $12.98^*
Shares after: 208,697
Date: 01 Sep 2023
Ownership: Direct

NBIX transaction

Common Stock

Sale

Transaction value: $550,316
Shares: -5,000
Change %: -2.4%
Price: $110.06
Shares after: 203,697
Date: 01 Sep 2023
Ownership: Direct
Footnotes: F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NBIX transaction Derivative

Non-Qualified Stock Option

Options Exercise

Transaction value: $64,900
Shares: -5,000
Change %: -33%
Price: $12.98^*
Shares after: 10,000
Date: 01 Sep 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price: $12.98
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Footnote F2

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.26. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F3

The reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power.

Footnote F4

Option granted May 22, 2014 and vested monthly over one year.